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Abstract
Background: The length of time for cigarette smoke (CS) exposure to cause emphysema in mice is drastically
reduced when CS exposure is combined with viral infection. However, the extent of inflammatory responses and
lung pathologies of mice exposed to CS and infected with influenza A virus (IAV), respiratory syncytial virus (RSV), or
treated with the viral derivative dsRNA (polyinosine-polycytidylic acid [poly (I:C)] have not been compared.
Methods: Mice were exposed to CS or filtered air for 4 weeks and received a single dose of vehicle, AV, or RSV infection
and extent of inflammation and emphysema was evaluated 14 d later. In another set of experiments, mice were instilled
with poly (I:C) twice a week during the third and fourth weeks of CS exposure and immediately analyzed for extent of
inflammation and lung pathologies.
Results: In CS-exposed mice, inflammation was characterized mainly by macrophages, lymphocytes, and neutrophils
after IAV infection, mainly by lymphocytes, and neutrophils after RSV infection, and mainly by lymphocytes and
neutrophils after poly (I:C) instillations. Despite increased inflammation, extent of emphysema by poly (I:C) was
very mild; but was robust and similar for both IAV and RSV infections with enhanced MMP-12 mRNA expression
and TUNEL positivity. Both IAV and RSV infections increased the levels of IL-17, IL-1β, IL-12b, IL-18, IL-23a, Ccl-2,
Ccl-7 mRNAs in the lungs of CS-exposed mice with IAV causing more increases than RSV.
Conclusion: CS-induced inflammatory responses and extent of emphysematous changes differ depending on the
type of viral infection. These animal models may be useful to study the mechanisms by which different viruses
exacerbate CS-induced inflammation and emphysema.
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Background
Chronic obstructive pulmonary disease (COPD), includ-
ing emphysema and chronic bronchitis, is the third lead-
ing cause of death in the US [1]. COPD refers to a broad
group of lung diseases with airflow limitation, parenchymal
destruction, fibrosis around small airways involving several
different cells (neutrophils, macrophage, CD8 lymphocytes)
[2, 3], and small-airway obstruction [4]. The most studied
of these conditions is emphysema, which is characterized
by permanent inflammation and irreversible destruction of
alveolar walls, leading to airspace enlargement and loss of
elastic recoil and hyperinflation [5]. Exposure to CS ac-
counts for about 80 % of all COPD cases [6–9], but other
factors when combined with cigarette smoke play a role in
exacerbating CS-induced COPD [10, 11]. Repeated inci-
dences of COPD exacerbations are associated with more
rapid disease progression, poorer quality of life, and higher
risk of mortality [12, 13]. Environmental pollutants, includ-
ing wood smoke [10, 14, 15–17] and diesel exhaust [18]
play a role in enhancing CS-induced inflammation.
Bacterial and viral infections are also major causes for
COPD exacerbations [19–25] leading to decline in lung
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function and concomitant acute deterioration in respira-
tory health [12]. Interestingly, as many as 40 to 60 % of all
exacerbations are attributed to respiratory viral infections
alone [26, 27].
Interactions between CS exposure and viral infection
induce exaggerated inflammatory and tissue remodeling
responses [28, 29]. Viral infections, such as IAV [30–32]
and respiratory syncytial virus (RSV) [19, 24, 25] are as-
sociated with acute COPD exacerbations, but the sever-
ity of infection in patients with COPD depends on both
viral and host factors [33]. For example, RSV accounts
for a quarter of all viral-induced COPD exacerbations
[19, 24, 25] and is an important respiratory pathogen in
the elderly, particularly in those with chronic lung dis-
eases such as COPD [23–25]. Approximately 60 million
people currently smoke cigarettes in the US alone, and
many of the immunocompromised elderly individuals
are susceptible to RSV infections and will have recurrent
seasonal flu infections. To understand disease progression
and develop better therapies, establishing animal models
that reflect these conditions in humans is crucial.
While the development of emphysema in mice requires
an exposure to CS for 4–8 months [34–38], infection with
respiratory viruses enhances CS-induced inflammation
and causes emphysema within 6 weeks [28].
The purpose of the current study was to establish
mouse models that recapitulate the cardinal features of
COPD within a short period of time by comparing ex-
tent of inflammation and emphysema after a 4 week CS
exposure in combination with a single infection of either
IAV, RSV, or multiple instillation with Poly(I:C). We show
that such a 2-hit system enhances lung inflammation and
the development of emphysema. Despite these similarities,
these animal models also showed major differences in the
type and extent of inflammation and alveolar destruction.
Methods
Cigarette smoke exposure and virus infection
Previous studies have shown that female mice are more
susceptible to CS-induced lung injury and develop emphy-
sema earlier than male mice from the same strain [37].
Therefore, 6 to 8 week old female C57BL/6 mice were pur-
chased from Jackson Laboratories (Bar Harbor, ME) and
housed in a pathogen-free facility. Mice were exposed in
whole body Hazelton 1000 chambers as described [37]
using Type 2R4F research cigarettes (Kentucky Tobacco
Research and Development Center). A computer-based
system provided 24-h monitoring and recording of airflow
rate, temperature, humidity, and pressure of the exposure
chambers. Previous studies have shown that infection with
up to 105 pfu of mouse-adapted strain of H3N3-HKx31
IAV or 107 pfu of RSV [39] cause significant inflamma-
tory responses in the lungs of C57BL/6 mice without
causing fatality for at least 14 days [40, 41] (and
personal observation). Because infection was going to
be combined with exposure to CS, we used 5 × 103 pfu
H3N3-HKx31 IAV or 4 × 106 pfu RSV to account death
of mice that may already have lost weight after 4 weeks
of CS exposure. To reduce mortality, mice were first
conditioned to CS by exposing them to 100 mg total
particulate matter (TPM)/m3 (6 h/day, 5 days/week) for
the first week and then to 250 mg TPM/m3 (6 h/day,
5 days/week) over weeks 2–4. Mice were then intranasally
instilled with VEHICLE (FA-Vehicle or CS-Vehicle) or 5 ×
103 pfu of mouse-adapted strain of H3N3-HKx31 IAV
(FA-IAV or CS-IAV) or 4 × 106 pfu RSV (FA-RSV or
CS-RSV), and euthanized at day 14 post viral challenge
(Fig. 1a). In the Poly(I:C) study group, mice were ex-
posed to FA or CS for 6 h/day, 5 days/week, and during
the third and fourth week of CS exposure instilled twice
a week with 50 μl of VEHICLE (FA-Vehicle or CS-
Vehicle) or poly(I:C) (FA-Poly(I:C) or CS-Poly(I:C))
(50 μg/50 μl) as described [28], and sacrificed at the
end of the 4 weeks of CS exposure (Fig. 1b). All studies
were conducted at Lovelace Respiratory Research Institute,
a facility approved by the Association for the Assessment
and Accreditation for Laboratory Animal Care Inter-
national. All experiments were pre-approved by the
Lovelace Respiratory Research Institute Institutional
Animal Care and Use Committee (IACUC), and the
Environmental Safety and Health department (ES&H)
with protocol reference numbers FY11-006 and FY09-024.
Lung inflammatory cells, histology and morphometry
Mice were euthanized by lethal injection of pentobarbital
sodium followed by exsanguination. Lung inflammatory
cells were recovered by bronchoalveolar lavage (BAL) and
total recovered cells were counted in BAL fluid (BALF)
and immune cell types in the BALF were quantified after
staining cytospins using a Diff-quik kit (Siemens Health-
care Diagnostics, Inc., Newark, DE) per manufacturer’s dir-
ection. For lung histology and morphometry, lungs were
inflated and fixed with 4 % buffered paraformaldehyde at a
constant hydrostatic pressure of 25 cm for 4 h and further
immersed in fixative for 48 h. The inflated lungs were em-
bedded in paraffin and 5 μm sagittal sections were stained
with hematoxylin and eosin (H&E) for histological evalu-
ation as described [42]. To analyze inflammation-
associated lung damages, H&E–stained lung tissues were
evaluated in a blinded manner with a semi-quantitative
system according to the relative degree of inflammation
and tissue damage. Inflammatory changes were evaluated
and described by a board certified pathologist. Lung in-
flammatory changes were graded based on the following
parameters: peri-bronchiolar and bronchial infiltrates,
bronchiolar and bronchial luminal exudates, perivascular
infiltrates, parenchymal pneumonia, and edema, as previ-
ously described [43–46]. Each parameter was graded on a
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scale of 0–4 with 0, absent; 1, slight; 2, mild; 3, moderate;
and 4, severe. The cumulative scores of inflammatory
infiltration, degeneration and necrosis provided the
total score per animal, and the average score of mice in
each group was taken as total score for that group.
Morphometric analysis of alveolar volume measure-
ment was carried out using the Visiomorph module of
VisioPharm analysis software (Visiopharm, Hoersholm,
Denmark).
TUNEL assay
We analyzed fixed lung tissues from each group for cells
with internucleosomal DNA fragmentation using the
TUNEL assay, as described elsewhere [47, 48]. Briefly,
terminal deoxynucleotidyltransferase was used to incorp-
orate biotin-16-dUTP into the ends of DNA fragments.
For lung tissues from each group with internucleosomal
DNA fragmentation TUNEL signals were visualized using
the Vectastain avidin-biotin complex kit and the peroxid-
ase substrate diaminobenzidine (Vector Laboratories,
Burlingame, CA) and microscopy (Zeiss) as described
by the manufacturer.
Analysis of mRNA levels
Total RNA was isolated from snap-frozen lung tissue
using the RNeasy mini kit (Qiagen, Valencia, CA) which
included a 10 min on-column DNAse treatment. Mouse
IL17 RT2 Profiler PCR array (SA Biosciences, Valencia,
CA) was used to analyze host gene expression on samples
from lungs of mice exposed to FA or CS and infected with
IAV or RSV. SA Biosciences web based RT2 profiler PCR
array data analysis program was used to calculate fold
changes. Quantitative TaqMan RT-PCR was performed fol-
lowing manufacturer’s instructions (Applied Biosystems,
Foster City, CA) to measure mRNA levels for IL-17a,
IL-17c, IL-17d, IL-17 f. IL-1β, IL-12b, IL-18, IL-23a,
Ccl-2, Ccl-7 at day 4 post infection in lung tissue sam-
ples from Vehicle- or IAV- or RSV-infected mice ex-
posed to FA or CS. Quantitative RT-PCR analysis for
MMP-12 mRNA was performed at day 14 post infection.
Viral load was evaluated by quantitative RT-PCR using
TaqMan primer and probe that detects IAV M and RSV
NS1 gene mRNAs. RT-PCR was performed in an ABI
Prism 7900 Sequence Detection System (Applied Bio-
systems) using universal thermal cycling parameters.
Gene expression was analyzed using the comparative
CT method after normalization to GAPDH of Vehicle
infected, C-exposed mice.
Data analysis
Data were analyzed and graphed using GraphPad PRISM
version 5.04. Data were generally analyzed using one-way
ANOVA, and when significance was detected, the Fisher’s
exact least significant difference test was used to determine
differences between groups. Body weight comparisons
were analyzed using ANOVA with repeated measures,
followed by a post hoc Fisher’s least significance differ-
ence test. Viral titres in the lung were compared using
an unpaired Student’s two-tailed t-test. Comparisons of
inflammatory cells, weighted mean alveolar volume, mean
linear intercepts, inflammation scores, MMP-12 RNA levels
and TUNEL positivity among groups were analyzed using
ANOVA followed by Tukey’s Multiple Comparison
Test. Unless otherwise stated data are presented as
mean +/− standard error of mean (SEM) for at least 6
mice/group. Probability values less than 0.05 were con-
sidered significant.
Fig. 1 Schematic diagram of the study design for cigarette smoke exposure and infection with IAV or RSV or Poly (I:C) treatment. C57BL/6 mice
were first exposed to mainstream cigarette smoke (6 h/day, 5 days/week; 1 week at 100TPM/m3 and 3 weeks at 250TPM/m3) (CS) or filtered air
(FA). a Mice were intranasally instilled with vehicle or 5 × 103 pfu IAV (IAV) or 4 × 106 pfu RSV (RSV) and lung tissues were harvested at 4 or 14 days
post infection. b Mice were instilled twice a week with 50 μl of poly (I:C) (50 μg/50 μl) on the third and fourth week of CS exposure and lung tissues
were harvested at the end of the 4 weeks of exposure
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Results
Lung inflammation in CS-exposed mice when infected with
IAV and RSV
To study the relative significance of different respiratory
viruses we first compared changes in body weight over
time after infection. Previous studies reported that CS
exposure reduces the body weight of mice [11, 37]. We
found that IAV significantly reduced body weight in both
FA- and CS-exposed mice (Fig. 2a). However, RSV infec-
tion or instillation with the viral derivative Poly (I:C)
affect the body weight in CS-exposed but not in FA-
exposed mice (Fig. 2b and c). We compared the viral
load in the lung tissues of FA-IAV/RSV or CS-IAV/RSV
mice on d 4 and 14 of infection using qRT-PCR and
found that both IAV M and RSV NS1 gene copy numbers
were significantly reduced in CS-IAV/RSV compared to
FA-IAV/RSV lung tissues at 4 d post infection. However,
the viral load was much higher in CS-IAV/RSV groups
compared to FA-IAV/RSV mice in both IAV- and
RSV-infected groups at 14 d post infection although the
overall viral load was lower in both FA and CS-exposed
mice compared to that found at 4 d (Fig. 3a and b).
The total number of inflammatory cells recovered in
the broncho-alveolar lavage (BAL) increased signifi-
cantly in CS-Vehicle compared to FA-Vehicle controls
(Fig. 4a, e, and i). Exposure to CS caused approximately
2-fold increases in BAL macrophages, which were fur-
ther increased by IAV and poly(I:C) but not RSV
(Fig. 4b, f, and j). Overall, both RSV or poly(I:C) showed
significantly lower macrophage numbers in the BAL
(Fig. 4b, f, j). FA-IAV or FA-RSV mice had significantly
increased number of BAL lymphocytes compared to FA-
Vehicle mice, but the increases in BAL lymphocytes by
poly(I:C) were not significant. However, CS exposure sig-
nificantly enhanced the number of BAL lymphocytes in
IAV, RSV- or poly (I:C)-treated groups (Fig. 4c, g, and k).
Exposure to CS increased the number of BAL neutrophils
in vehicle-treated mice. The BAL neutrophil levels were
increased by infection with IAV, RSV or poly(I:C) alone,
which were further enhanced by exposure to CS
(Fig. 4d, h, and l). Relative to their respective CS-
Vehicle groups, CS-poly(I:C) compared to CS-RSV and
CS-IAV caused the most neutrophilic inflammation
(Fig. 4l). Together, these results suggest that, in CS-
injured lungs, while IAV infection had a synergistic effect
in increasing the number of macrophages and lympho-
cytes and slightly neutrophils, RSV mainly caused further
increases in lymphocytes and somewhat for neutrophils,
and poly(I:C) primarily caused increases in lymphocytes
and neutrophils.
Lung inflammatory changes were graded in H&E stained
lung tissues. Generally, smoke alone caused mild in-
flammation consisting of mild peri-bronchovascular,
broncho-alveolar and septal alveolar macrophage accu-
mulation with some pigmentation. FA-IAV (Fig. 5a) or
FA-RSV (Fig. 5b) caused enhanced inflammation with
Fig. 2 C57BL/6 mice exposed to FA or CS for 4 weeks, intranasally instilled with vehicle or (a) IAV or (b) RSV and euthanized at day 14 post viral
challenge. Percent changes in body weights were compared at different time points. c C57BL/6 mice were exposed to FA or CS for 4 weeks,
instilled twice a week with 50 μl of poly(I:C) (50 μg/50 μl) or vehicle on the third and fourth week of FA (poly(I:C)FA) or CS (poly(I:C)CS) exposure.
Percent changes in body weight were compared. N = 6 mice per group * p < 0.05
Fig. 3 IAV and RSV infections persist longer in CS-injured lungs.
Viral load was compared in the lung tissues of FA- or CS-exposed
mice on d 4 and 14 of infection with (a) IAV or (b) RSV using
qRT-PCR. Total RNA was isolated from snap-frozen lung tissues
and quantitative TaqMan RT-PCR analysis was performed to assess IAV
M1 or RSV NS1 gene expression. Samples were normalized to
mouse GAPDH RNA levels. N = 6 mice per group; data reported as
mean ± SEM. *p < 0.05
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prominent inflammatory cells surrounding the alveoli,
bronchi and the parenchyma with FA-IAV showing
more of neutrophilic and monocytic infiltrates at the
broncho-vascular junction and FA-RSV showing mainly
infiltrates of lymphocytes with some macrophages. The
lung tissues from FA-poly(I:C) and CS-Poly(I:C) showed
infiltrates of macrophages, neutrophils, lymphocytes and
some necrosis, with more severe infiltration of inflamma-
tory cells in the CS-poly(I:C) group (Fig. 5c). Compared
to FA-IAV or FA-RSV mice, inflammation was more
pronounced in the lung tissues of CS-IAV (Fig. 5a) and
CS-RSV mice (Fig. 5b), respectively. When compared
to FA-poly(I:C) group, inflammation was also signifi-
cantly increased in the lung tissues of CS- poly(I:C)
mice; however, inflammation was milder compared to
CS-IAV- or CS-RSV groups (Fig. 5c). Alcian blue/peri-
odic acid Schiff (AB/PAS) staining showed that there
were some mucous cells in the airways of FA-IAV, FA-
RSV, or FA-poly(I:C) treated mice with some increases
in CS-IAV, CS-RSV, and CS-poly(I:C) groups. However,
no major differences in mucous hypersecretion between
the three different groups was observed (data not shown).
Infection with IAV or RSV leads to the development of
emphysema in CS-exposed lung
Morphometric analysis on H&E-stained lung sections
showed that IAV (Fig. 6a, b, and c) or RSV (Fig. 6d, e
and f) caused significant increases in volume weighted
mean alveolar volume (Fig. 6b and e) and mean linear
intercepts (Lm) (Fig. 6c and f) in mice exposed to CS at
day 14 post infections. While poly(I:C) showed no sig-
nificant increase in the weighted mean alveolar volume,
the mean linear intercept (Lm) was significant increase
(Fig. 6g, h, i), suggesting that the difference to vehicle
and CS-exposed groups was minimal.
IAV and RSV infections increase the expression of IL-17
and its upstream regulators
Because the poly(I:C) group showed minimal change in
emphysema, we continued further analyses with the IAV
Fig. 4 CS injury alters inflammatory cell recruitment in response to IAV, RSV, or Poly (I:C). BAL was performed on (a-h) FA-Vehicle, CS-Vehicle,
FA-IAV/RSV and CS-IAV/RSV mice 14 post viral challenge or (i-l) FA-Vehicle, CS-Vehicle, FA-poly(I:C) and CS-poly(I:C) mice instilled with 50 μl of
poly (I:C) (50 μg/50 μl) or vehicle twice a week on the third and fourth week of CS exposure. Total cell counts (a, e, i), and differential analysis
for macrophages (b, f, j), lymphocytes (c, g, k) and neutrophils (d, h, l) were performed on isolated BAL cells. N = 6 mice per group; data reported as
mean ± SE; * p < 0.05, ** p < 0.01, ***p < 0.001
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Fig. 5 (See legend on next page.)
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Fig. 5 Inflammation score in H&E-stained lung tissues from (a) IAV-infected or (b) RSV-infected or (c) Poly (I:C) instilled mice with or without exposure
to CS on day 14 post infection. The arrows in FA-IAV image indicate neutrophilic and monocytic infiltrates at the bronchovascular junction, in
the CS-Vehicle image indicate alveolar macrophage accumulation, in CS-IAV indicate infiltrates of monocytes, lymphocytes and neutrophils.
The arrows in FA-RSV indicate infiltrates of lymphocytes and some macrophages, in CS-RSV images indicate infiltrates of lymphocytes and
monocytes around the vessels, and neutropils and necrotic cell debris in the airways. The arrows in FA-poly(I;C) and CS-Poly(I:C) images indicate
infiltrates of macrophages, and lymphocytes with some necrosis. Inflammation scores were evaluated as described in MATERIALS AND METHODS.
N = 6 mice per group; data reported as mean ± SE; * p < 0.05, ** p < 0.01, ***p < 0.001
Fig. 6 Alterations in alveolar structure and volume by IAV, RSV or Poly (I:C) in the CS-exposed lungs. a-f Mice were exposed to FA or CS for
4 weeks and instilled with vehicle or (a-c) IAV or (d-f) RSV, and euthanized at day 14 post viral challenge. g-i C57BL/6 mice were exposed to FA
or CS for 4 weeks, instilled twice a week with 50 μl of poly(I:C) (50 μg/50 μl) or vehicle on the third and fourth week of CS exposure. Mice were
euthanized at the end of 4 weeks of FA or CS exposure. Representative images (a, d, g), morphometric analysis for volume weighted mean alveolar
volume (b, e, h), and mean alveolar chord length (c, f, i) of lungs inflated and fixed with formalin under constant pressure. N = 8 mice per group; data
reported as mean ± SE; *p < 0.05, **p < 0.01, ***p < 0.001
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and RSV-infected mice. Previous studies have shown that
IL-17, an important mediator of CS-induced emphysema,
induces the expression of inflammatory cytokines and
matrix degrading proteinases MMP-9 and MMP-12 [49].
We found that infection with IAV or RSV caused an al-
tered inflammatory response in FA-exposed or CS-injured
lungs. IAV and RSV infection increased the expression of
more than 26 and 16 cytokine-encoding genes in the
lungs of CS-exposed mice compared to FA-exposed
mice, respectively (Fig. 7). Therefore, we selected specific
IL-17-related cytokines and chemokines and further inves-
tigated whether IAV or RSV have synergistic effects to en-
hance the expression these genes in CS-exposed lungs.
IAV or RSV infection enhanced lung mRNA levels for
IL-17a, IL-17c, IL-17d, IL-17f, IL-1β, IL-12b, IL-18, IL-23a,
Ccl-2, and Ccl-7 in CS-exposed mice. However, IAV caused
more increases in the IL-17-related cytokines and chemo-
kines tested than RSV in CS-exposed mice (Table 1).
IAV and RSV infections enhance the expression of MMP-12
in cigarette smoke-injured lung
The proteinase MMP-12 is an important enzyme in the
development and progression and emphysema [50, 51].
Although IAV was used at a lower titer, IAV (Fig. 8a),
but not RSV (Fig. 8b) infection increased MMP-12
mRNA levels in FA-exposed mice. Overall, four weeks of
exposure to CS compared with FA caused significant
increases in the MMP-12 mRNA levels. However, in
CS-exposed mice, both IAV (Fig. 8a) and RSV (Fig. 8a)
infections synergistically enhanced MMP-12 mRNA ex-
pression with IAV infection more than RSV.
Apoptosis plays an important role in the development
of emphysema [52–54]. Analyses for internucleosomal
DNA fragmentation using the TUNEL assay showed that
neither IAV nor RSV infection alone caused significant
increase in TUNEL positivity in FA-exposed group. Com-
pared to FA-exposed mice, CS-exposed mice had signifi-
cant increase in TUNEL positivity in the lung tissues and
these increases were further enhanced equally by both
IAV (Fig. 8c) and RSV infection (Fig. 8d).
Discussion
The present study utilized mouse models with existing
CS exposure to compare extent of inflammatory re-
sponses and tissue destruction when infected with IAV,
RSV, or instilled with Poly (I:C). When comparing these
three models, one needs to consider the differences in
the viral titers for IAV and RSV used to infect the mice.
In addition, multiple doses of Poly (I:C) were delivered
to mice over the last two weeks of CS exposure, and
mice were euthanized right after 4 weeks of exposure to
CS and were not kept for an additional 14 days in FA as
in the cases with IAV and RSV groups. Repeated admin-
istration was chosen to compensate for the lack of repli-
cation in the poly(I:C) group.
We found that by day 4 post infection CS-exposed
groups had significantly lower copy number of viruses than
the FA groups for both IAV and RSV study groups. This
may be due to early induction of type I IFN by cigarette
smoke [28, 55], which may suppress virus replication. As
inflammation progresses, IFN response may wane resulting
in delayed viral clearance and more titer in CS-injured
lungs than FA-exposed lungs on day 14 post infection.
While the overall total numbers of inflammatory cells
recovered in the BAL of CS-IAV/RSV and CS-poly(I:C)
mice were synergistically increased, differences in the
type and degree of inflammatory responses were observed
among these groups. The CS-IAV group displayed in-
creased number of macrophages and lymphocytes with
few neutrophils, and CS-RSV group showed increased
lymphocytes and neutrophils, similar to that observed in
the CS-poly(I:C) group. These findings are consistent with
previous studies showing that IAV or poly (I:C) lead to
additive effects in the level of BAL inflammatory cells in
mice exposed to CS [28, 56]. Interestingly, despite higher
titers used for RSV, IAV caused more inflammation sug-
gesting that different viruses have distinct inflammatory
patterns either alone or when combined with CS expos-
ure. Macrophages and neutrophils are the main sources of
proteases in lungs, and there are correlations between the
degree of macrophage and neutrophil inflammation and
Fig. 7 IAV or RSV infections induce IL-17 in cigarette smoke-injured lung. C57BL/6 mice were exposed for 4 weeks to FA or CS and infected with
Vehicle or IAV or RSV. RNA was isolated from lung tissues and IL17 RT2 Profile PCR array was performed for IL-17 regulated genes at day 4 p.i. All
samples were normalized to mouse GAPDH RNA levels. Heat map blocks represent average RNA levels N = 6 mice per group and are normalized
to FA samples
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severity of airflow obstruction [57]. Although significant
increases in the BAL neutrophils were observed among
the models tested, poly (I:C) caused the mildest form of
emphysema in CS-exposed mice. For the poly(I:C) group,
emphysema measures were assessed at 4 weeks of CS
exposure while the IAV and IAV groups of mice were
assessed 14 d later. Further, IAV or RSV alone did not
cause increases in alveolar spaces compared to their
respective vehicle controls. Hence, it is possible that
the poly(I:C) group could develop more pronounced
structural changes in CS-exposed mice similar to the
virally challenged groups given the appropriate time
for the changes to develop. Emphysema that develops
in mice after 6 months of exposure remains pro-
nounced even 6 months later [37], and future studies
will need to examine the persistence of the observed
emphysematous changes several months after the ini-
tial infections.
Both IAV and RSV infection induced IL-17a, IL-17b,
IL-17d, and IL-17f, IL-1β, IL-12b, IL-18, IL-23, Ccl-2,
and Ccl-7 mRNA levels in the lungs of CS-injured mice.
CD8+ T-lymphocytes are critical for the induction of in-
flammation and tissue destruction in a murine model of
smoke-induced emphysema [58]. CD4+ T cells, upon ac-
tivation and expansion, develop into different T helper
cell subsets with different cytokine profiles and distinct
effector functions [59]. Thus, IAV or RSV in CS-exposed
mice may cause the differentiation of Th17 cells or may
affect γδ T cells, NK cells, and neutrophils to produce
IL-17 in response to CS exposure dependent induction
of IL-1β, IL-18, or IL-23 [60]. Despite higher titer for
RSV, IAV was more potent in increasing expression of
IL-17a, IL-17c, IL-12b, IL-18, IL-23a, IL-1β, Ccl-2, and
Ccl-7 than RSV. It is possible that cytokine expression
was also increased in the poly(I:C) group, but emphyse-
matous changes were not apparent. Although we did not
compare cytokine in the lungs of this group of mice with
the RSV and IAV groups, a study using CS-poly(I:C)
mouse model showed that poly(I:C) was a potent stimu-
lator of IL-18, IL-12/IL-23 p40, and type I and type II
IFNs with significantly greater responses in mice ex-
posed to CS compared with mice in FA. This study sug-
gest that IL-18Rα and IFN-γ play critical role in the
pathogenesis of the inflammation and remodeling that is
induced by CS plus poly(I:C). IAV [43, 61] and RSV [62]
have been shown to induce Th17-related cytokines. Fu-
ture studies will elucidate the specific roles of the differ-
ent cytokines and chemokines in IAV- or RSV-infected
or poly(I:C) treated mice exposed to CS.
In mice, IL-17 is essential for the development of em-
physema from long term CS exposure [49] by activating
the IL-17→ Ccl-2→MMP-9→MMP-12 signaling axis
[49]. Increases in IL-17-regulated genes and chemokines
such as Ccl-2 and Ccl-7 are associated with COPD
Fig. 8 CS injury induces MMP12 in the lungs in response to IAV or RSV. a-b C57BL/6 mice were exposed for 4 weeks to FA or CS and instilled
intranasal with Vehicle, (a) IAV or (b) RSV. Quantitative RT-PCR analysis for MMP-12 mRNA was performed at day 14 post viral infection. All
samples were normalized to mouse GAPDH RNA levels. c-d Lung tissues from FA- or CS-exposed mice instilled intranasal with vehicle or (c)
IAV or (d) RSV were analyzed for internucleosomal DNA fragmentation using TUNEL assay. N = 6 mice per group; data reported as mean ± SE;
*p < 0.05; **p < 0.01, ***p < 0.001













amRNA isolated at day 4 post infection was analyzed by qRT-PCR and normal-
ized to mouse GAPDH RNA. Data are presented as fold change in CS-IAV/RSV
compared with CS-Vehicle groups
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progression in humans [63–65]. This is consistent with
our data showing that increased IL-17 expression was
associated with increased expression of MMP-12 mRNA
levels. Mouse models with MMP-12-deficient macro-
phages [51, 66] and pharmacological inhibition of MMP-
12 [66] showed that MMP-12 activity plays an important
role in the development of emphysema.
It has long been believed that, in cigarette smoke–in-
duced COPD, the alveolar destruction and enlargement
is a direct consequence of inflammation and the associ-
ated imbalance in the extracellular matrix protease and
antiprotease response, which leads to degradation of the
elastin [67]. However, despite differences in inflammatory
responses, IAV and RSV infections led to similar extent of
emphysema in the CS-exposed mice. Further, IAV and
RSV infections significantly enhanced TUNEL positivity
and upregulation of the MMP-12 mRNA to a similar ex-
tent. Also, despite increases in inflammation by poly (I:C)
similar to RSV, extent of emphysema caused by poly (I:C)
was milder. These findings suggests that inflammation
does not necessarily correlate with lung pathology as was
shown for CS-induced emphysema in C3H and C57Bl/6
mice [11]. It is also possible that regardless of extent of
lung inflammation, the severity of alveolar destruction and
airspace enlargement in mice remains mild [37], likely be-
cause of lung structure or length of chronic inflammation.
While infection with RSV leads to differentiation of Th17
cells [62, 68] and is associated with skewing the immune
system away from the Th1 response [69], poly (I:C) may
cause more Th1 than Th17 differentiation [70, 71]. Fur-
thermore, although poly (I:C) activates TLR3 [72], repeated
doses of poly (I:C) induce inflammation and alveolar re-
modeling via pathways independent of TLR3 [28]. Future
studies will investigate the role of innate versus Th17 im-
munity in the pathogenesis of IAV-, RSV-, and poly (I:C)-
induced lung inflammation in CS-exposed mice.
Both weighted mean alveolar volume and Lm are useful
parameters of peripheral lung structure and have utility in
studying experimental emphysema [73, 74]. However, Lm re-
flects the dimensions of alveoli but is not a direct estimate of
alveolar diameter or mean alveolar size. Although weighted
mean alveolar volume, Lm, and indexes of lung elasticity are
correlated in excised non-diseased lungs of humans [75] and
several animal species [76] Lm may not be the most accurate
measure. Lm is a function of lung volume [76, 77] but may
not be able to separate the effects of tissue destruction from
those on tissue distension and from any changes in lung elas-
ticity that results in changes in lung volume, as would be ex-
pected with emphysema. Thus, conclusions drawn from Lm
alone should be interpreted with caution.
Conclusion
Our studies demonstrate that IAV, RSV or poly (I:C)
augment CS-induced airway and alveolar inflammation
and remodeling in the murine lung. This study affirms
that both RSV and IAV are key etiological factors driving
cytokine, protease, and apoptotic responses that lead to
airspace enlargements. However, there were significant
differences in the type and extent of inflammation in-
volved. The minimal emphysematous changes in the
poly(I:C) group, compared to the CS-IAV and CS-RSV
group, may be attributed to the differences in the study
design and the shorter time elapsed between exposure to
CS and analyses of the lung tissues. Future studies
should elucidate the cause-effect relationships between
inflammation and alveolar destruction in detail to dissect
differences between these models to help translate these
findings to patients with COPD exacerbations.
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